Capital International’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-134,990
Closed -$10.8M 124
2016
Q4
$10.8M Sell
134,990
-1,400
-1% -$111K 0.76% 50
2016
Q3
$10.9M Sell
136,390
-3,700
-3% -$299K 0.77% 52
2016
Q2
$10.9M Sell
140,090
-12,100
-8% -$863K 0.79% 50
2016
Q1
$8.37M Sell
152,190
-83,000
-35% -$4.52M 0.54% 65
2015
Q4
$14.5M Sell
235,190
-50,050
-18% -$3.16M 0.92% 40
2015
Q3
$18M Sell
285,240
-17,700
-6% -$1.26M 1.19% 28
2015
Q2
$22.1M Buy
302,940
+58,250
+24% +$4.21M 1.31% 28
2015
Q1
$16M Buy
244,690
+2,400
+1% +$160K 0.98% 39
2014
Q4
$15.8M Buy
242,290
+218,090
+901% +$14M 0.96% 39
2014
Q3
$1.46M Hold
24,200
0.09% 111
2014
Q2
$1.68M Buy
+24,200
New +$1.57M 0.1% 105

Other funds holding STJ

Capital International's STJ Position: Q1 2017 in Review

Capital International sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 134,990 shares — an estimated $10.8M sold.

Capital International first reported a position in STJ in Q2 2014 and held it in 11 quarters. The position peaked at $22.1M in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Capital International reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Capital International sold 134,990 St Jude Medical shares in Q1 2017, an estimated $10.8M.
  • Capital International first reported a position in St Jude Medical in Q2 2014 and held it in 11 quarters.
  • Capital International's St Jude Medical position peaked at $22.1M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Capital International's 13F filing for Q1 2017, filed 15 May 2017.